An experimental drug for rectal cancer caused all patients' tumors to disappear in a small trial

An experimental drug for rectal cancer caused all patients’ tumors to disappear in a small trial

In an unprecedented clinical trial, dozens of rectal cancer patients saw their tumors disappear after they received an experimental drug called dostarlimab, and none of the patients experienced significant side effects from the treatment.

“I think this is the first time this has happened in history cancerIn terms of this being the first cancer trial in which every patient is in recovery, Dr. Luis Alberto Diaz Jr., one of the trial leaders and an oncologist at Memorial Sloan Kettering (MSK) Cancer Center, He told the New York Times, (Opens in a new tab).

2022-06-06 20:42:53

Leave a Comment

Your email address will not be published. Required fields are marked *